The approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and Managing Director of the Hyderabad-based pharmaceutical firm said in a statement.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rMHQnB
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of Covaxin
0 comments:
Post a Comment